Trial: 201703178

A Phase 2 Trial of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer

Phase

II

Principal Investigator

Pachynski, Russell

Disease Site

Prostate

Learn more about this study at: clinicaltrials.gov